Literature DB >> 17664234

Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus.

M V Febronio1, R M R Pereira, E Bonfa, A D Takiuti, E A G Pereyra, C A A Silva.   

Abstract

To evaluate cervicovaginal cytology in adolescents with juvenile systemic lupus erythematosus (JSLE) and to compare them to controls. Fifty-two female adolescents with JSLE (ACR criteria) were compared to 52 age-matched healthy controls. All Pap smears were evaluated by the same cytopathologist blinded to gynecology examination (Bethesda 2001). The mean age of JSLE patients and controls were similar (16.17 +/- 1.94 versus 16.13 +/- 2.16 years, P = 0.92). The cervicovaginal cytology was found to be similar in both groups, although sexual intercourses in the last month were less frequent in JSLE than controls (23% versus 59.6%, P = 0.0003). Only one patient (2%) with JSLE versus two controls (4%) had cervical dysplasia (LGSIL) and human papilomavirus (P = 1.0). Candida spp vaginitis was observed in seven JSLE (14%) versus none in controls (P = 0.012) and was associated with immunosuppressive drugs (P = 0.01) and high dose of prednisone (P = 0.002). Of interest, inflammatory cervicovaginal cytology was observed in 21 (60%) of patients with SLEDAI > or = 4 and only four (23%) of those with SLEDAI < 4 (P = 0.001). Likewise, a higher frequency of inflammatory changes was also observed in virgin JSLE (57% versus 8%, P = 0.005). Our findings supports the notion that female genital tract may be a potential target organ in SLE since cervical inflammation is associated to disease activity independently of sexual activity.

Entities:  

Mesh:

Year:  2007        PMID: 17664234     DOI: 10.1177/0961203307079298

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

Review 1.  Taxonomy for systemic lupus erythematosus with onset before adulthood.

Authors:  Clovis A Silva; Tadej Avcin; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

Review 2.  Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review.

Authors:  Iuri Usêda Santana; Alline do Nascimento Gomes; Leomar D'Cirqueira Lyrio; Maria Fernanda Rios Grassi; Mittermayer Barreto Santiago
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 2.980

3.  Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.

Authors:  Mariana G Waisberg; Ana C M Ribeiro; Wellington M Candido; Poliana B Medeiros; Cezar N Matsuzaki; Mariana C Beldi; Maricy Tacla; Helio H Caiaffa-Filho; Eloísa Bonfa; Clovis A Silva
Journal:  Rheumatol Int       Date:  2014-10-28       Impact factor: 2.631

4.  Malignancy in systemic lupus erythematosus: what have we learned?

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-08       Impact factor: 4.098

5.  Penile alterations with severe sperm abnormalities in antiphospholipid syndrome associated with systemic lupus erythematosus.

Authors:  Carlos Nobre Rabelo-Júnior; Eloisa Bonfá; Jozélio F Carvalho; Marcello Cocuzza; Osmar Saito; Carmita H Abdo; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2012-09-11       Impact factor: 2.980

6.  Substance misuse and sexual function in adolescents with chronic diseases.

Authors:  Priscila Araújo; Márcio Guilherme Nunes Carvalho; Marlon van Weelden; Benito Lourenço; Lígia Bruni Queiroz; Clovis Artur Silva
Journal:  Rev Paul Pediatr       Date:  2016-06-02

7.  Screening tests of reproductive immunology in systemic lupus erythematosus.

Authors:  Zdenka Ulcova-Gallova; Alice Mockova; Miroslava Cedikova
Journal:  Autoimmune Dis       Date:  2012-10-24

8.  The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus.

Authors:  Claudia Mendoza-Pinto; Mario Garcia-Carrasco; Veronica Vallejo-Ruiz; Alejandro Taboada-Cole; Margarita Muñoz-Guarneros; Juan Carlos Solis-Poblano; Elias Pezzat-Said; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suarez; Luis Vazquez de Lara; Gloria Ramos-Alvarez; Julio Reyes-Leyva; Aurelio Lopez-Colombo
Journal:  Clinics (Sao Paulo)       Date:  2013-12       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.